Benitec Biopharma (BNTC) Current Leases: 2020-2025
Historic Current Leases for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $346,000.
- Benitec Biopharma's Current Leases rose 18.49% to $346,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $346,000, marking a year-over-year increase of 18.49%. This contributed to the annual value of $284,000 for FY2024, which is 3.27% up from last year.
- Latest data reveals that Benitec Biopharma reported Current Leases of $346,000 as of Q1 2025, which was up 152.55% from $137,000 recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Current Leases registered a high of $346,000 during Q1 2025, and its lowest value of $137,000 during Q4 2024.
- For the 3-year period, Benitec Biopharma's Current Leases averaged around $264,444, with its median value being $280,000 (2023).
- As far as peak fluctuations go, Benitec Biopharma's Current Leases skyrocketed by 32.99% in 2022, and later plummeted by 52.10% in 2024.
- Benitec Biopharma's Current Leases (Quarterly) stood at $213,000 in 2021, then rose by 23.47% to $263,000 in 2022, then rose by 8.75% to $286,000 in 2023, then slumped by 52.10% to $137,000 in 2024, then rose by 18.49% to $346,000 in 2025.
- Its Current Leases stands at $346,000 for Q1 2025, versus $137,000 for Q4 2024 and $211,000 for Q3 2024.